Stay updated with breaking news from Weak Guidance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's specialty testing capabilities.
AbbVie's Upadacitinib outperforms dupilumab in Phase 3b/4 study for atopic dermatitis treatment, achieving superior efficacy and rapid skin clearance than Dupixent.
Sonic Automotive (SAH) stock surges over 9% post-earnings, beating EPS estimates, despite a slight revenue decline, CFO optimistic about future success.
Detroit's restaurant scene is shifting due to the pandemic. Jeremy Sasson's Heirloom Hospitality is adapting by creating unique dining experiences.
Moderna and MSD have announced follow-up data from the Phase IIb clinical trial evaluating cancer vaccine mRNA-4157 in combination with MSD's Keytruda in patients with resected high-risk...